Treasurer of the State of North Carolina’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-40,084
Closed -$556K 1031
2022
Q1
$556K Buy
40,084
+630
+2% +$9.9K ﹤0.01% 988
2021
Q4
$1.11M Buy
39,454
+260
+0.7% +$7.97K 0.01% 958
2021
Q3
$1.33M Buy
39,194
+1,319
+3% +$47.7K 0.01% 935
2021
Q2
$1.55M Buy
37,875
+9,920
+35% +$386K 0.01% 910
2021
Q1
$1.13M Sell
27,955
-70
-0.2% -$3.79K 0.01% 935
2020
Q4
$1.66M Buy
28,025
+70
+0.3% +$3.61K 0.01% 818
2020
Q3
$1.36M Buy
27,955
+1,840
+7% +$77.3K 0.01% 806
2020
Q2
$1.26M Sell
26,115
-1,425
-5% -$52K 0.01% 835
2020
Q1
$765K Buy
+27,540
New +$768K 0.01% 871

Other funds holding ADPT

Treasurer of the State of North Carolina's ADPT Position: Q2 2022 in Review

Treasurer of the State of North Carolina sold out of Adaptive Biotechnologies (ADPT) in Q2 2022, closing a stake of 40,084 shares — an estimated $556K sold.

Treasurer of the State of North Carolina first reported a position in ADPT in Q1 2020 and held it in 9 quarters. The position peaked at $1.66M in Q4 2020. 209 funds tracked by Wall St. Rank hold ADPT as of Q2 2022.

  • Treasurer of the State of North Carolina reported no remaining Adaptive Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 40,084 Adaptive Biotechnologies shares in Q2 2022, an estimated $556K.
  • Treasurer of the State of North Carolina first reported a position in Adaptive Biotechnologies in Q1 2020 and held it in 9 quarters.
  • Treasurer of the State of North Carolina's Adaptive Biotechnologies position peaked at $1.66M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2022.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2022, filed 2 Aug 2022.